フルタミドの世界市場レポート2020

• 英文タイトル：Global Flutamide (CAS 13311-84-7) Sales Market Report 2020

• レポートコード：QY20ST-06955 • 出版社/出版日：QYResearch / 2020年9月25日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、131ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療

• 販売価格（消費税別）

Single User	￥560,000 (USD4,000)	▷ お問い合わせ
Multi User	￥840,000 (USD6,000)	▷ お問い合わせ
Enterprise License	￥1,120,000 (USD8,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、世界のフルタミド市場について種類別（フルタミド錠、フルタミドカプセル、その他）、用途別（病院薬局、小売薬局、オンライン薬局）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・フルタミド市場の概要 ・世界の主要地域別フルタミド市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のフルタミド市場規模2015-2026：種類別（フルタミド錠、フルタミドカプセル、その他） ・世界のフルタミド市場規模2015-2026：用途別（病院薬局、小売薬局、オンライン薬局） ・フルタミドの北米市場規模2015-2020 ・フルタミドのヨーロッパ市場規模2015-2020 ・フルタミドの中国市場規模2015-2020 ・フルタミドの日本市場規模2015-2020 ・フルタミドの東南アジア市場規模2015-2020 ・フルタミドのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・フルタミドの製造コスト分析 ・販売チャネル、流通業者、顧客 ・フルタミドの市場動向・機会・課題 ・調査の結論

A recently published report by QY Research titled Global Flutamide (CAS 13311-84-7) Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Flutamide (CAS 13311-84-7) market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Flutamide (CAS 13311-84-7), C11H11F3N2O3, the formula weight is 276.21, and its form is yellow powder.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Flutamide (CAS 13311-84-7) market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Flutamide (CAS 13311-84-7) industry.
Based on our recent survey, we have several different scenarios about the Flutamide (CAS 13311-84-7) YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Flutamide (CAS 13311-84-7) will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Flutamide (CAS 13311-84-7) market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Flutamide (CAS 13311-84-7) market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Flutamide (CAS 13311-84-7) market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Flutamide (CAS 13311-84-7) market. The report also includes nautical information, where it shows Flutamide (CAS 13311-84-7) market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Flutamide (CAS 13311-84-7) market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Flutamide (CAS 13311-84-7) market.
Flutamide is used for prostate cancer or benign prostatic hypertrophy. This product can be combined with leucolide to treat metastatic prostate cancer, which can significantly increase the efficacy.
Geographical Analysis:
Based on region, the global Flutamide (CAS 13311-84-7) market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Flutamide (CAS 13311-84-7) market are
Forward
Merck
Tasly Diyi Pharma
Cipla LifeScience
Actiza Pharma
TEVA Pharma
Florencia Healthcare
SANDOZ
Segment by Type
Flutamide Tablets
Flutamide Capsule
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Flutamide (CAS 13311-84-7) market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Flutamide (CAS 13311-84-7) market.
• The market share of the global Flutamide (CAS 13311-84-7) market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Flutamide (CAS 13311-84-7) market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Flutamide (CAS 13311-84-7) market.

レポート目次

---

1 Flutamide (CAS 13311-84-7) Market Overview
1.1 Flutamide (CAS 13311-84-7) Product Scope
1.2 Flutamide (CAS 13311-84-7) Segment by Type
1.2.1 Global Flutamide (CAS 13311-84-7) Sales by Type (2020-2026)
1.2.2 Flutamide Tablets
1.2.3 Flutamide Capsule
1.2.4 Others
1.3 Flutamide (CAS 13311-84-7) Segment by Application
1.3.1 Global Flutamide (CAS 13311-84-7) Sales Comparison by Application (2020-2026)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Flutamide (CAS 13311-84-7) Market Estimates and Forecasts (2015-2026)
1.4.1 Global Flutamide (CAS 13311-84-7) Sales Growth Rate (2015-2026)
1.4.2 Global Flutamide (CAS 13311-84-7) Revenue and Growth Rate (2015-2026)
1.4.3 Global Flutamide (CAS 13311-84-7) Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Flutamide (CAS 13311-84-7) Industry Impact
1.5.1 How the Covid-19 is Affecting the Flutamide (CAS 13311-84-7) Industry
1.5.1.1 Flutamide (CAS 13311-84-7) Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Flutamide (CAS 13311-84-7) Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Flutamide (CAS 13311-84-7) Players to Combat Covid-19 Impact

2 Flutamide (CAS 13311-84-7) Estimate and Forecast by Region
2.1 Global Flutamide (CAS 13311-84-7) Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Flutamide (CAS 13311-84-7) Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Flutamide (CAS 13311-84-7) Sales Market Share by Region (2015-2020)
2.2.2 Global Flutamide (CAS 13311-84-7) Revenue Market Share by Region (2015-2020)
2.3 Global Flutamide (CAS 13311-84-7) Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Flutamide (CAS 13311-84-7) Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Flutamide (CAS 13311-84-7) Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Flutamide (CAS 13311-84-7) Estimates and Projections (2015-2026)
2.4.2 Europe Flutamide (CAS 13311-84-7) Estimates and Projections (2015-2026)
2.4.3 China Flutamide (CAS 13311-84-7) Estimates and Projections (2015-2026)
2.4.4 Japan Flutamide (CAS 13311-84-7) Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Flutamide (CAS 13311-84-7) Estimates and Projections (2015-2026)
2.4.6 India Flutamide (CAS 13311-84-7) Estimates and Projections (2015-2026)
3 Global Flutamide (CAS 13311-84-7) Competition Landscape by Players
3.1 Global Top Flutamide (CAS 13311-84-7) Players by Sales (2015-2020)
3.2 Global Top Flutamide (CAS 13311-84-7) Players by Revenue (2015-2020)
3.3 Global Flutamide (CAS 13311-84-7) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Flutamide (CAS 13311-84-7) as of 2019)
3.4 Global Flutamide (CAS 13311-84-7) Average Price by Company (2015-2020)
3.5 Manufacturers Flutamide (CAS 13311-84-7) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Flutamide (CAS 13311-84-7) Players (Opinion Leaders)
4 Global Flutamide (CAS 13311-84-7) Market Size by Type
4.1 Global Flutamide (CAS 13311-84-7) Historic Market Review by Type (2015-2020)
4.1.1 Global Flutamide (CAS 13311-84-7) Sales Market Share by Type (2015-2020)
4.1.2 Global Flutamide (CAS 13311-84-7) Revenue Market Share by Type (2015-2020)
4.1.3 Global Flutamide (CAS 13311-84-7) Price by Type (2014-2020)
4.2 Global Flutamide (CAS 13311-84-7) Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Flutamide (CAS 13311-84-7) Sales Forecast by Type (2021-2026)
4.2.2 Global Flutamide (CAS 13311-84-7) Revenue Forecast by Type (2021-2026)
4.2.3 Global Flutamide (CAS 13311-84-7) Price Forecast by Type (2021-2026)
5 Global Flutamide (CAS 13311-84-7) Market Size by Application
5.1 Global Flutamide (CAS 13311-84-7) Historic Market Review by Application (2015-2020)
5.1.1 Global Flutamide (CAS 13311-84-7) Sales Market Share by Application (2015-2020)
5.1.2 Global Flutamide (CAS 13311-84-7) Revenue Market Share by Application (2015-2020)
5.1.3 Global Flutamide (CAS 13311-84-7) Price by Application (2015-2020)
5.2 Global Flutamide (CAS 13311-84-7) Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Flutamide (CAS 13311-84-7) Sales Forecast by Application (2021-2026)
5.2.2 Global Flutamide (CAS 13311-84-7) Revenue Forecast by Application (2021-2026)
5.2.3 Global Flutamide (CAS 13311-84-7) Price Forecast by Application (2021-2026)

3 North America Flutamide (CAS 13311-84-7) Market Facts & Figures
3.2 North America Flutamide (CAS 13311-84-7) Sales Market Share by Company (2015-2020)
3.3 North America Flutamide (CAS 13311-84-7) Sales Market Share by Type (2015-2020)
3.4 North America Flutamide (CAS 13311-84-7) Sales Market Share by Application (2015-2020)

4 Europe Flutamide (CAS 13311-84-7) Market Facts & Figures
4.2 Europe Flutamide (CAS 13311-84-7) Sales Market Share by Company (2015-2020)
4.3 Europe Flutamide (CAS 13311-84-7) Sales Market Share by Type (2015-2020)
4.4 Europe Flutamide (CAS 13311-84-7) Sales Market Share by Application (2015-2020)

5 China Flutamide (CAS 13311-84-7) Market Facts & Figures
5.2 China Flutamide (CAS 13311-84-7) Sales Market Share by Company (2015-2020)
5.3 China Flutamide (CAS 13311-84-7) Sales Market Share by Type (2015-2020)
5.4 China Flutamide (CAS 13311-84-7) Sales Market Share by Application (2015-2020)

6 Japan Flutamide (CAS 13311-84-7) Market Facts & Figures
6.2 Japan Flutamide (CAS 13311-84-7) Sales Market Share by Company (2015-2020)
6.3 Japan Flutamide (CAS 13311-84-7) Sales Market Share by Type (2015-2020)
6.4 Japan Flutamide (CAS 13311-84-7) Sales Market Share by Application (2015-2020)

7 Southeast Asia Flutamide (CAS 13311-84-7) Market Facts & Figures
7.2 Southeast Asia Flutamide (CAS 13311-84-7) Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Flutamide (CAS 13311-84-7) Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Flutamide (CAS 13311-84-7) Sales Market Share by Application (2015-2020)

8 India Flutamide (CAS 13311-84-7) Market Facts & Figures
8.2 India Flutamide (CAS 13311-84-7) Sales Market Share by Company (2015-2020)
8.3 India Flutamide (CAS 13311-84-7) Sales Market Share by Type (2015-2020)
8.4 India Flutamide (CAS 13311-84-7) Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Flutamide (CAS 13311-84-7) Business
12.1 Forward
12.1.1 Forward Flutamide (CAS 13311-84-7) Corporation Information
12.1.2 Forward Flutamide (CAS 13311-84-7) Business Overview and Total Revenue
12.1.3 Forward Flutamide (CAS 13311-84-7) Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Forward Flutamide (CAS 13311-84-7) Products Offered
12.1.5 Forward Recent Development
12.2 Merck
12.2.1 Merck Flutamide (CAS 13311-84-7) Corporation Information
12.2.2 Merck Flutamide (CAS 13311-84-7) Business Overview and Total Revenue
12.2.3 Merck Flutamide (CAS 13311-84-7) Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Merck Flutamide (CAS 13311-84-7) Products Offered
12.2.5 Merck Recent Development
12.3 Tasly Diyi Pharma
12.3.1 Tasly Diyi Pharma Flutamide (CAS 13311-84-7) Corporation Information
12.3.2 Tasly Diyi Pharma Flutamide (CAS 13311-84-7) Business Overview and Total Revenue
12.3.3 Tasly Diyi Pharma Flutamide (CAS 13311-84-7) Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Tasly Diyi Pharma Flutamide (CAS 13311-84-7) Products Offered
12.3.5 Tasly Diyi Pharma Recent Development
12.4 Cipla LifeScience
12.4.1 Cipla LifeScience Flutamide (CAS 13311-84-7) Corporation Information
12.4.2 Cipla LifeScience Flutamide (CAS 13311-84-7) Business Overview and Total Revenue
12.4.3 Cipla LifeScience Flutamide (CAS 13311-84-7) Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Cipla LifeScience Flutamide (CAS 13311-84-7) Products Offered
12.4.5 Cipla LifeScience Recent Development
12.5 Actiza Pharma
12.5.1 Actiza Pharma Flutamide (CAS 13311-84-7) Corporation Information
12.5.2 Actiza Pharma Flutamide (CAS 13311-84-7) Business Overview and Total Revenue
12.5.3 Actiza Pharma Flutamide (CAS 13311-84-7) Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Actiza Pharma Flutamide (CAS 13311-84-7) Products Offered
12.5.5 Actiza Pharma Recent Development
12.6 TEVA Pharma
12.6.1 TEVA Pharma Flutamide (CAS 13311-84-7) Corporation Information
12.6.2 TEVA Pharma Flutamide (CAS 13311-84-7) Business Overview and Total Revenue
12.6.3 TEVA Pharma Flutamide (CAS 13311-84-7) Sales, Revenue and Gross Margin (2015-2020)
12.6.4 TEVA Pharma Flutamide (CAS 13311-84-7) Products Offered
12.6.5 TEVA Pharma Recent Development
12.7 Florencia Healthcare
12.7.1 Florencia Healthcare Flutamide (CAS 13311-84-7) Corporation Information
12.7.2 Florencia Healthcare Flutamide (CAS 13311-84-7) Business Overview and Total Revenue
12.7.3 Florencia Healthcare Flutamide (CAS 13311-84-7) Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Florencia Healthcare Flutamide (CAS 13311-84-7) Products Offered
12.7.5 Florencia Healthcare Recent Development
12.8 SANDOZ
12.8.1 SANDOZ Flutamide (CAS 13311-84-7) Corporation Information
12.8.2 SANDOZ Flutamide (CAS 13311-84-7) Business Overview and Total Revenue
12.8.3 SANDOZ Flutamide (CAS 13311-84-7) Sales, Revenue and Gross Margin (2015-2020)
12.8.4 SANDOZ Flutamide (CAS 13311-84-7) Products Offered
12.8.5 SANDOZ Recent Development

13 Flutamide (CAS 13311-84-7) Manufacturing Cost Analysis
13.1 Flutamide (CAS 13311-84-7) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Flutamide (CAS 13311-84-7)
13.4 Flutamide (CAS 13311-84-7) Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Flutamide (CAS 13311-84-7) Distributors List
14.3 Flutamide (CAS 13311-84-7) Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Flutamide (CAS 13311-84-7) Sales (Kg) Growth Rate by Type (2020-2026)
Table 2. Global Flutamide (CAS 13311-84-7) Sales (Kg) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Flutamide (CAS 13311-84-7) Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Flutamide (CAS 13311-84-7) Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Flutamide (CAS 13311-84-7) Players to Combat Covid-19 Impact
Table 8. Global Market Flutamide (CAS 13311-84-7) Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Flutamide (CAS 13311-84-7) Sales (Kg) by Region (2015-2020)
Table 10. Global Flutamide (CAS 13311-84-7) Sales Market Share by Region (2015-2020)
Table 11. Global Flutamide (CAS 13311-84-7) Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Flutamide (CAS 13311-84-7) Revenue Share by Region (2015-2020)
Table 13. Global Flutamide (CAS 13311-84-7) Sales (Kg) Forecast by Region (2021-2026)
Table 14. Global Flutamide (CAS 13311-84-7) Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Flutamide (CAS 13311-84-7) Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Flutamide (CAS 13311-84-7) Revenue Share Forecast by Region (2021-2026)
Table 17. Global Flutamide (CAS 13311-84-7) (Kg) of Key Companies (2015-2020)
Table 18. Global Flutamide (CAS 13311-84-7) Sales Share by Company (2015-2020)
Table 19. Global Flutamide (CAS 13311-84-7) Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Flutamide (CAS 13311-84-7) Revenue Share by Company (2015-2020)
Table 21. Global Flutamide (CAS 13311-84-7) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Flutamide (CAS 13311-84-7) as of 2019)
Table 22. Global Flutamide (CAS 13311-84-7) Average Price (USD/Kg) of Key Company (2015-2020)
Table 23. Manufacturers Flutamide (CAS 13311-84-7) Manufacturing Sites and Area Served
Table 24. Manufacturers Flutamide (CAS 13311-84-7) Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Flutamide (CAS 13311-84-7) Players
Table 27. Global Flutamide (CAS 13311-84-7) Sales (Kg) by Type (2015-2020)
Table 28. Global Flutamide (CAS 13311-84-7) Sales Share by Type (2015-2020)
Table 29. Global Flutamide (CAS 13311-84-7) Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Flutamide (CAS 13311-84-7) Price (Kg) by Type (2015-2020)
Table 31. Global Flutamide (CAS 13311-84-7) Sales Share by Type (2021-2026)
Table 32. Global Flutamide (CAS 13311-84-7) Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Flutamide (CAS 13311-84-7) Revenue Share by Type (2021-2026)
Table 34. Global Flutamide (CAS 13311-84-7) Price (Kg) by Type (2021-2026)
Table 35. Global Flutamide (CAS 13311-84-7) Sales (Kg) by Application (2015-2020)
Table 36. Global Flutamide (CAS 13311-84-7) Sales Share by Application (2015-2020)
Table 37. Global Flutamide (CAS 13311-84-7) Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Flutamide (CAS 13311-84-7) Price (Kg) by Application (2015-2020)
Table 39. Global Flutamide (CAS 13311-84-7) Sales (Kg) by Application (2021-2026)
Table 40. Global Flutamide (CAS 13311-84-7) Sales Share by Application (2021-2026)
Table 41. Global Flutamide (CAS 13311-84-7) Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Flutamide (CAS 13311-84-7) Revenue Share by Application (2021-2026)
Table 43. Global Flutamide (CAS 13311-84-7) Price (Kg) by Application (2021-2026)
Table 44. United States Flutamide (CAS 13311-84-7) Sales (Kg) by Company (2015-2020)
Table 45. United States Flutamide (CAS 13311-84-7) Sales Market Share by Company (2015-2020)
Table 46. United States Flutamide (CAS 13311-84-7) Sales (Kg) by Type (2015-2020)
Table 47. United States Flutamide (CAS 13311-84-7) Sales Market Share by Type (2015-2020)
Table 48. United States Flutamide (CAS 13311-84-7) Sales (Kg) by Application (2015-2020)
Table 49. United States Flutamide (CAS 13311-84-7) Sales Market Share by Application (2015-2020)
Table 50. Europe Flutamide (CAS 13311-84-7) Sales (Kg) by Company (2015-2020)
Table 51. Europe Flutamide (CAS 13311-84-7) Sales Market Share by Company (2015-2020)
Table 52. Europe Flutamide (CAS 13311-84-7) Sales (Kg) by Type (2015-2020)
Table 53. Europe Flutamide (CAS 13311-84-7) Sales Market Share by Type (2015-2020)
Table 54. Europe Flutamide (CAS 13311-84-7) Sales (Kg) by Application (2015-2020)
Table 55. Europe Flutamide (CAS 13311-84-7) Sales Market Share by Type (2015-2020)
Table 56. China Flutamide (CAS 13311-84-7) Sales (Kg) by Company (2015-2020)
Table 57. China Flutamide (CAS 13311-84-7) Sales Market Share by Company (2015-2020)
Table 58. China Flutamide (CAS 13311-84-7) Sales (Kg) by Type (2015-2020)
Table 59. China Flutamide (CAS 13311-84-7) Sales Market Share by Type (2015-2020)
Table 60. China Flutamide (CAS 13311-84-7) Sales (Kg) by Application (2015-2020)
Table 61. China Flutamide (CAS 13311-84-7) Sales Market Share by Application (2015-2020)
Table 62. Japan Flutamide (CAS 13311-84-7) Sales (Kg) by Company (2015-2020)
Table 63. Japan Flutamide (CAS 13311-84-7) Sales Market Share by Company (2015-2020)
Table 64. Japan Flutamide (CAS 13311-84-7) Sales (Kg) by Type (2015-2020)
Table 65. Japan Flutamide (CAS 13311-84-7) Sales Market Share by Type (2015-2020)
Table 66. Japan Flutamide (CAS 13311-84-7) Sales (Kg) by Application (2015-2020)
Table 67. Japan Flutamide (CAS 13311-84-7) Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Flutamide (CAS 13311-84-7) Sales (Kg) by Company (2015-2020)
Table 69. Southeast Asia Flutamide (CAS 13311-84-7) Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Flutamide (CAS 13311-84-7) Sales (Kg) by Type (2015-2020)
Table 71. Southeast Asia Flutamide (CAS 13311-84-7) Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Flutamide (CAS 13311-84-7) Sales (Kg) by Type (2015-2020)
Table 73. Southeast Asia Flutamide (CAS 13311-84-7) Sales Market Share by Application (2015-2020)
Table 74. India Flutamide (CAS 13311-84-7) Sales (Kg) by Company (2015-2020)
Table 75. India Flutamide (CAS 13311-84-7) Sales Market Share by Company (2015-2020)
Table 76. India Flutamide (CAS 13311-84-7) Sales (Kg) by Type (2015-2020)
Table 77. India Flutamide (CAS 13311-84-7) Sales Market Share by Type (2015-2020)
Table 78. India Flutamide (CAS 13311-84-7) Sales (Kg) by Application (2015-2020)
Table 79. India Flutamide (CAS 13311-84-7) Sales Market Share by Application (2015-2020)
Table 80. Forward Corporation Information
Table 81. Forward Description and Business Overview
Table 82. Forward Flutamide (CAS 13311-84-7) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 83. Forward Flutamide (CAS 13311-84-7) Product
Table 84. Forward Recent Development
Table 85. Merck Corporation Information
Table 86. Merck Description and Business Overview
Table 87. Merck Flutamide (CAS 13311-84-7) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 88. Merck Flutamide (CAS 13311-84-7) Product
Table 89. Merck Recent Development
Table 90. Tasly Diyi Pharma Corporation Information
Table 91. Tasly Diyi Pharma Description and Business Overview
Table 92. Tasly Diyi Pharma Flutamide (CAS 13311-84-7) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 93. Tasly Diyi Pharma Flutamide (CAS 13311-84-7) Product
Table 94. Tasly Diyi Pharma Recent Development
Table 95. Cipla LifeScience Corporation Information
Table 96. Cipla LifeScience Description and Business Overview
Table 97. Cipla LifeScience Flutamide (CAS 13311-84-7) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 98. Cipla LifeScience Flutamide (CAS 13311-84-7) Product
Table 99. Cipla LifeScience Recent Development
Table 100. Actiza Pharma Corporation Information
Table 101. Actiza Pharma Description and Business Overview
Table 102. Actiza Pharma Flutamide (CAS 13311-84-7) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 103. Actiza Pharma Flutamide (CAS 13311-84-7) Product
Table 104. Actiza Pharma Recent Development
Table 105. TEVA Pharma Corporation Information
Table 106. TEVA Pharma Description and Business Overview
Table 107. TEVA Pharma Flutamide (CAS 13311-84-7) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 108. TEVA Pharma Flutamide (CAS 13311-84-7) Product
Table 109. TEVA Pharma Recent Development
Table 110. Florencia Healthcare Corporation Information
Table 111. Florencia Healthcare Description and Business Overview
Table 112. Florencia Healthcare Flutamide (CAS 13311-84-7) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 113. Florencia Healthcare Flutamide (CAS 13311-84-7) Product
Table 114. Florencia Healthcare Recent Development
Table . SANDOZ Corporation Information
Table . SANDOZ Flutamide (CAS 13311-84-7) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table . SANDOZ Description and Business Overview
Table . SANDOZ Flutamide (CAS 13311-84-7) Product
Table . SANDOZ Recent Development
Table 120. Production Base and Market Concentration Rate of Raw Material
Table 121. Key Suppliers of Raw Materials
Table 122. Flutamide (CAS 13311-84-7) Distributors List
Table 123. Flutamide (CAS 13311-84-7) Customers List
Table 124. Market Key Trends
Table 125. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 126. Key Challenges
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Flutamide (CAS 13311-84-7) Product Picture
Figure 2. Global Flutamide (CAS 13311-84-7) Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Flutamide (CAS 13311-84-7) Market Share by Application in 2020 & 2026
Figure 6. Hospital Pharmacies Examples
Figure 7. Retail Pharmacies Examples
Figure 8. Online Pharmacies Examples
Figure 9. Global Flutamide (CAS 13311-84-7) Sales (Kg) Growth Rate (2015-2026)
Figure 10. Global Flutamide (CAS 13311-84-7) Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Flutamide (CAS 13311-84-7) Price Trends Growth Rate (2015-2026) (USD/Kg)
Figure 12. Global Flutamide (CAS 13311-84-7) Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Flutamide (CAS 13311-84-7) Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Flutamide (CAS 13311-84-7) Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Flutamide (CAS 13311-84-7) Sales (Kg) Growth Rate (2015-2026)
Figure 16. Europe Flutamide (CAS 13311-84-7) Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Flutamide (CAS 13311-84-7) Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Flutamide (CAS 13311-84-7) Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Flutamide (CAS 13311-84-7) Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Flutamide (CAS 13311-84-7) Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Flutamide (CAS 13311-84-7) Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Flutamide (CAS 13311-84-7) Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Flutamide (CAS 13311-84-7) Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Flutamide (CAS 13311-84-7) Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Flutamide (CAS 13311-84-7) Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Flutamide (CAS 13311-84-7) Players Market Share by Revenue in Flutamide (CAS 13311-84-7) 2015 & 2019
Figure 27. Flutamide (CAS 13311-84-7) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Flutamide (CAS 13311-84-7) Revenue Share by Type (2015-2020)
Figure 29. Global Flutamide (CAS 13311-84-7) Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Flutamide (CAS 13311-84-7) Revenue Share by Application (2015-2020)
Figure 31. Global Flutamide (CAS 13311-84-7) Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Flutamide (CAS 13311-84-7) Sales Market Share by Type in 2019
Figure 33. United States Flutamide (CAS 13311-84-7) Sales Market Share by Type in 2019
Figure 34. Europe Flutamide (CAS 13311-84-7) Sales Market Share by Company in 2019
Figure 35. Europe Flutamide (CAS 13311-84-7) Sales Market Share by Type in 2019
Figure 36. Europe Flutamide (CAS 13311-84-7) Sales Market Share by Application in 2019
Figure 37. China Flutamide (CAS 13311-84-7) Sales Market Share by Company in 2019
Figure 38. China Flutamide (CAS 13311-84-7) Sales Market Share by Type in 2019
Figure 39. China Flutamide (CAS 13311-84-7) Sales Market Share by Application in 2019
Figure 40. Japan Flutamide (CAS 13311-84-7) Sales Market Share by Company in 2019
Figure 41. Japan Flutamide (CAS 13311-84-7) Sales Market Share by Type in 2019
Figure 42. Japan Flutamide (CAS 13311-84-7) Sales Market Share by Application in 2019
Figure 43. Southeast Asia Flutamide (CAS 13311-84-7) Sales Market Share by Company in 2019
Figure 44. Southeast Asia Flutamide (CAS 13311-84-7) Sales Market Share by Type in 2019
Figure 45. Southeast Asia Flutamide (CAS 13311-84-7) Sales Market Share by Application in 2019
Figure 46. India Flutamide (CAS 13311-84-7) Sales Market Share by Company in 2019
Figure 47. India Flutamide (CAS 13311-84-7) Sales Market Share by Type in 2019
Figure 48. India Flutamide (CAS 13311-84-7) Sales Market Share by Application in 2019
Figure 49. Forward Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Tasly Diyi Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Cipla LifeScience Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Actiza Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. TEVA Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Florencia Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. SANDOZ Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Key Raw Materials Price Trend
Figure 58. Manufacturing Cost Structure of Flutamide (CAS 13311-84-7)
Figure 59. Manufacturing Process Analysis of Flutamide (CAS 13311-84-7)
Figure 60. Flutamide (CAS 13311-84-7) Industrial Chain Analysis
Figure 61. Channels of Distribution
Figure 62. Distributors Profiles
Figure 63. Porter's Five Forces Analysis
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

---